ASIC Inquiry and Short Sellers Drown Out DroneShield’s NATO Catalyst

Australian counter-drone firm DroneShield sees shares tumble over 60% from peak as ASIC investigation and 12% short interest overshadow NATO's $40B Drone Edge initiative and product upgrades.

A company with a full order book, a freshly announced NATO mega-program, and a string of product upgrades — yet its shares have shed over 60% from their peak. That is the paradox gripping DroneShield, the Australian counter-drone specialist whose stock has been pummelled by a regulatory investigation and relentless short-selling, even as the West pours billions into air defence.

Last week’s NATO “Drone Edge” initiative, a five-year, $40 billion programme backed by 20 member states including Sweden and Finland, was supposed to be a tailwind for any company in the unmanned defence space. But on the day of the announcement, DroneShield’s shares actually fell 4.21% to €1.39. A modest 3.73% recovery on Friday lifted the close to €1.46, only for the stock to slide again on Monday, finishing at €1.41. The market’s verdict: a multilateral framework is not a signed contract with DroneShield itself, and a far more immediate overhang — the Australian Securities and Investments Commission (ASIC) — is keeping buyers at bay.

ASIC Probe Casts a Long Shadow

ASIC’s investigation into DroneShield centres on the timing of past corporate disclosures and related share sales by executives, with the probe covering events since 2025. The regulator has not detailed the specific allegations, but the open file has already triggered a sharp re-rating. Analysts and short sellers alike point to this governance cloud as the primary reason operational milestones have failed to translate into share price gains.

The company has not been idle. On July 6 it rolled out a comprehensive software update for the third quarter of 2026, designed to counter fast-evolving threats such as FPV drones and coordinated swarm attacks. A week earlier, Rear Admiral Lee Goddard CSC — a 30-year veteran of defence, national security and industry — joined the board as an independent non-executive director. Yet neither move has stemmed the selling.

Technical Breakdown and Rising Short Interest

The chart tells a bleak story. The stock is trading well below its 50-day moving average of €1.76 and its 200-day average of €1.98, a configuration traders label a “death cross”. The 14-day relative strength index hovered near 37.9 on Monday, approaching oversold territory, while annualised 30-day volatility has climbed to 70.77% — a level that underscores how sensitive the shares are to any new headline.

Short sellers have smelled blood. Short interest in DroneShield has risen to roughly 12% of the float, consistently landing the stock among the most-shorted names on the ASX. The combination of an unresolved regulatory probe and a deteriorating technical picture has emboldened bears even as the company’s long-term growth thesis remains intact.

Analysts Split Down the Middle

Coverage on DroneShield is thin — just four analysts track the name, according to TradingView. They are evenly divided: two rate it a “Strong Buy”, two issue “Strong Sell” or equivalent. Canaccord Genuity is among the bulls, reiterating a buy rating with a 12-month target of A$3.75, implying roughly 62% upside from current levels. The most bullish price target on the Street suggests the stock could double. The bears, however, see further downside, warning that the ASIC inquiry could limit any near-term recovery.

A $40 Billion NATO Backdrop That Hasn’t Landed

NATO Secretary-General Mark Rutte unveiled the “Drone Edge” programme in Ankara with much fanfare, promising to accelerate fielding of proven counter-drone systems over five years. For a company whose entire business rests on detecting and neutralising uncrewed aircraft, the initiative reads like a tailor-made opportunity. Investors, however, are treating it as a long-term structural tailwind, not a near-term revenue event — especially while the governance cloud persists.

DroneShield’s market capitalisation stands at roughly €1.31 billion, a substantial valuation for a company under active investigation. Whether the NATO framework eventually translates into specific contracts for the firm will be the key variable in the months ahead. Until then, the stock remains caught between a multi-billion-dollar defence push and the cold reality of an open regulatory file — with short sellers betting that the latter will keep the pressure on for some time yet.